Icagen, Pfizer deal

Pfizer extended for the final time its subsequent tender offer for the remaining shares of Icagen at $6 per share in cash to 6 p.m. EDT on Sept. 19 from Sept. 12. As of Sept 12, 5.1 million shares had...